Literature DB >> 22984007

CT interpretation in a telestroke network: agreement among a spoke radiologist, hub vascular neurologist, and hub neuroradiologist.

Bart M Demaerschalk1, Bentley J Bobrow, Rema Raman, Karin Ernstrom, Joseph M Hoxworth, Ameet C Patel, Terri-Ellen J Kiernan, Maria I Aguilar, Timothy J Ingall, David W Dodick, Brett C Meyer.   

Abstract

BACKGROUND AND
PURPOSE: The American Stroke Association guidelines emphasized the need for further high-quality studies that assess agreement by radiologists and nonradiologists engaged in emergency telestroke assessments and decision-making. Therefore, the objective of this study was to determine the level of agreement of baseline brain CT scan interpretations of patients with acute stroke presenting to telestroke spoke hospitals between central reading committee neuroradiologists and each of 2 groups, spoke hospital radiologists and hub hospital vascular neurologists (telestrokologists).
METHODS: The Stroke Team Remote Evaluation Using a Digital Observation Camera Arizona trial was a prospective, urban single-hub, rural 2-spoke, randomized, blinded, controlled trial of a 2-way, site-independent, audiovisual telemedicine and teleradiology system designed for remote evaluation of adult patients with acute stroke versus telephone consultation to assess eligibility for treatment with intravenous thrombolysis. In the telemedicine arm, the subjects' CT scans were interpreted by the hub telestrokologist and in the telephone arm by the spoke radiologist. All subjects' CT scans were subsequently interpreted centrally, independently, and blindly by 2 hub neuroradiologists. The primary CT outcome was determination of a CT-based contraindication to thrombolytic treatment. Kappa statistics and exact agreement rates were used to analyze interobserver agreement.
RESULTS: Fifty-four subjects underwent random assignment. The overall agreement for the presence of radiological contraindications to thrombolysis was excellent (0.91) and did not differ substantially between the hub telestrokologist to neuroradiologist and spoke radiologist to neuroradiologist (0.92 and 0.89, respectively).
CONCLUSIONS: In the context of a telestroke network designed to assess patients with acute stroke syndromes, agreement over the presence or absence of radiological contraindications to thrombolysis was excellent whether the comparisons were between a telestrokologist and neuroradiologist or between spoke radiologist and neuroradiologist. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00623350.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22984007      PMCID: PMC3502613          DOI: 10.1161/STROKEAHA.112.666255

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  Efficacy of telemedicine for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona telestroke trials.

Authors:  Bart M Demaerschalk; Rema Raman; Karin Ernstrom; Brett C Meyer
Journal:  Telemed J E Health       Date:  2012-03-08       Impact factor: 3.536

2.  ASPECTS reading requires training and experience.

Authors:  Shelagh B Coutts; Michael D Hill; Andrew M Demchuk; Philip A Barber; J H Warwick Pexman; Alastair M Buchan
Journal:  Stroke       Date:  2003-09-11       Impact factor: 7.914

3.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.

Authors:  P A Barber; A M Demchuk; J Zhang; A M Buchan
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

4.  Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke.

Authors:  J H Pexman; P A Barber; M D Hill; R J Sevick; A M Demchuk; M E Hudon; W Y Hu; A M Buchan
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

5.  Prospective reliability of the STRokE DOC wireless/site independent telemedicine system.

Authors:  B C Meyer; P D Lyden; L Al-Khoury; Y Cheng; R Raman; R Fellman; J Beer; R Rao; J A Zivin
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

6.  Performance and function of a desktop viewer at Mayo Clinic Scottsdale.

Authors:  W G Eversman; W Pavlicek; B Zavalkovskiy; B J Erickson
Journal:  J Digit Imaging       Date:  2000-05       Impact factor: 4.056

7.  Interobserver variation of ASPECTS in real time.

Authors:  Shelagh B Coutts; Andrew M Demchuk; Philip A Barber; William Y Hu; Jessica E Simon; Alastair M Buchan; Michael D Hill
Journal:  Stroke       Date:  2004-04-08       Impact factor: 7.914

8.  Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study.

Authors:  Brett C Meyer; Rema Raman; Thomas Hemmen; Richard Obler; Justin A Zivin; Ramesh Rao; Ronald G Thomas; Patrick D Lyden
Journal:  Lancet Neurol       Date:  2008-09       Impact factor: 44.182

9.  Reliability of site-independent telemedicine when assessed by telemedicine-naive stroke practitioners.

Authors:  Brett C Meyer; Rema Raman; Marcus R Chacon; Matt Jensen; Janet D Werner
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Jul-Aug       Impact factor: 2.136

10.  The STRokE DOC trial technique: 'video clip, drip, and/or ship'.

Authors:  B C Meyer; R Raman; R Rao; R D Fellman; J Beer; J Werner; J A Zivin; P D Lyden
Journal:  Int J Stroke       Date:  2007-11       Impact factor: 5.266

View more
  16 in total

Review 1.  Imaging Acute Ischemic Stroke: Mapping Present and Future Clinical Practice.

Authors:  Aaron P Tansy; David S Liebeskind
Journal:  Curr Atheroscler Rep       Date:  2015-09       Impact factor: 5.113

2.  Telemedicine in Neurological Disorders: Opportunities and Challenges.

Authors:  Martina Chirra; Luca Marsili; Linsdey Wattley; Leonard L Sokol; Elizabeth Keeling; Simona Maule; Gabriele Sobrero; Carlo Alberto Artusi; Alberto Romagnolo; Maurizio Zibetti; Leonardo Lopiano; Alberto J Espay; Ahmed Z Obeidat; Aristide Merola
Journal:  Telemed J E Health       Date:  2018-08-23       Impact factor: 3.536

Review 3.  Telestroke.

Authors:  Oana M Dumitrascu; Bart M Demaerschalk
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 4.  Imaging of prehospital stroke therapeutics.

Authors:  Michelle P Lin; Nerses Sanossian; David S Liebeskind
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-08-04

5.  Pooled assessment of computed tomography interpretation by vascular neurologists in the STRokE DOC telestroke network.

Authors:  Ilana Spokoyny; Rema Raman; Karin Ernstrom; Bart M Demaerschalk; Patrick D Lyden; Thomas M Hemmen; Amy K Guzik; James Y Chen; Brett C Meyer
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-05-19       Impact factor: 2.136

Review 6.  The history and future of telestroke.

Authors:  David C Hess; Heinrich J Audebert
Journal:  Nat Rev Neurol       Date:  2013-05-07       Impact factor: 42.937

Review 7.  Telemedicine in pre-hospital care: a review of telemedicine applications in the pre-hospital environment.

Authors:  Ahjoku Amadi-Obi; Peadar Gilligan; Niall Owens; Cathal O'Donnell
Journal:  Int J Emerg Med       Date:  2014-07-05

8.  The neuroethics of disorders of consciousness: a brief history of evolving ideas.

Authors:  Michael J Young; Yelena G Bodien; Joseph T Giacino; Joseph J Fins; Robert D Truog; Leigh R Hochberg; Brian L Edlow
Journal:  Brain       Date:  2021-12-16       Impact factor: 13.501

Review 9.  Interactive telemedicine: effects on professional practice and health care outcomes.

Authors:  Gerd Flodgren; Antoine Rachas; Andrew J Farmer; Marco Inzitari; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2015-09-07

10.  A comparison of direct and two-stage transportation of patients to hospital in Poland.

Authors:  Anna Rosiek; Aleksandra Rosiek-Kryszewska; Łukasz Leksowski; Krzysztof Leksowski
Journal:  Int J Environ Res Public Health       Date:  2015-04-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.